Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: salience processing and fear inhibition processes.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: salience processing and fear inhibition processes.
- Published In:
- Psychoneuroendocrinology, 40, 242-56 (2014)
- Authors:
- Koch, Saskia B J, van Zuiden, Mirjam, Nawijn, Laura, Frijling, Jessie L, Veltman, Dick J, Olff, Miranda
- Database ID:
- RPEP-02420
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02420APA
Koch, Saskia B J; van Zuiden, Mirjam; Nawijn, Laura; Frijling, Jessie L; Veltman, Dick J; Olff, Miranda. (2014). Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: salience processing and fear inhibition processes.. Psychoneuroendocrinology, 40, 242-56. https://doi.org/10.1016/j.psyneuen.2013.11.018
MLA
Koch, Saskia B J, et al. "Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: salience processing and fear inhibition processes.." Psychoneuroendocrinology, 2014. https://doi.org/10.1016/j.psyneuen.2013.11.018
RethinkPeptides
RethinkPeptides Research Database. "Intranasal oxytocin as strategy for medication-enhanced psyc..." RPEP-02420. Retrieved from https://rethinkpeptides.com/research/koch-2014-intranasal-oxytocin-as-strategy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.